1967
DOI: 10.1016/s0140-6736(67)90850-1
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Treatment of Multiple Sclerosis With Corticotrophin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
26
0
2

Year Published

1974
1974
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(30 citation statements)
references
References 6 publications
2
26
0
2
Order By: Relevance
“…The article references earlier publications by Fog [8] and J nsson et al [9], who previously described similar outcomes of ACTH treatment based on their clinical observations. These and other similar data provide evidence that ACTH gel is beneficial in the treatment of acute MS [10,11].…”
Section: History and Practice Of Ms Relapse Treatments: From Adrenocosupporting
confidence: 72%
“…The article references earlier publications by Fog [8] and J nsson et al [9], who previously described similar outcomes of ACTH treatment based on their clinical observations. These and other similar data provide evidence that ACTH gel is beneficial in the treatment of acute MS [10,11].…”
Section: History and Practice Of Ms Relapse Treatments: From Adrenocosupporting
confidence: 72%
“…Although the results of the Cooperative Study (1970) in the U.S.A. tended to support this, the benefits over placebo were marginal and it was concluded that, for the individual patient with an acute exacerbation of multiple sclerosis, there is 'little evidence to justify the enthusiastic administration of ACTH'. The value of ACTH in chronic multiple sclerosis is even more doubtful, benefit being claimed by some (Alexander and Cass, 1963) and denied by others (Rinne et al, 1968;Millar et al, 1967).…”
Section: Discussionmentioning
confidence: 99%
“…Whether the overall degree of recovery is improved or the long-term course is altered is not known. [73][74][75] Intravenous methylprednisolone is the preferred treatment because of rapid onset of action, consistent benefits, and relatively few adverse effects. 74,76 For moderate-to-severe relapses, methylprednisolone, 1000 mg, by intravenous infusion daily for 3 to 5 days followed by oral prednisone tapering from 60 mg/d over 12 days is effective in accelerating neurologic recovery.…”
Section: My Recommendation For Mr Jmentioning
confidence: 99%